Everest Medicines Company

Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.

Last Funding Type: Series C
Headquarters: New York, New York, United States
Total Funding: 310000000.0
Employee Number: 51-100
Funding Status: IPO
Industry: Clinical Development
Technology: Biotechnology, Health Care, Pharmaceutical
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-06-03
Founded Date: 2017-01-01
Investors Number: 10.0